Click on image to view larger version.

Figure 1 The effect of atorvastatin therapy on vascular endothelial growth factor (VEGF) plasma levels. Two months of atorvastatin therapy (20 mg/d) decreased VEGF plasma levels (pg/ml) in patients with coronary artery disease (CAD) (white bars, *p < 0.05). No significant difference in VEGF plasma concentration between control patients (black bar) and CAD patients after treatment with atorvastatin could be observed. The VEGF concentrations in CAD patients tended to be higher compared to those in control patients (p = NS).